These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 5355155)

  • 21. Spontaneous burned-out acromegaly with preservation of normal human growth hormone responses: diagnostic, historical, theoretical, and treatment aspects.
    Ewer RW; Kotheimer TG
    Johns Hopkins Med J; 1970 Oct; 127(4):199-212. PubMed ID: 4320105
    [No Abstract]   [Full Text] [Related]  

  • 22. [Acromegaly].
    Morange I; Jaquet P
    Rev Prat; 1996 Jun; 46(12):1482-5. PubMed ID: 8881161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pituitary apoplexy, the Houssay phenomenon, and accelerated proliferative retinopathy.
    Petersen P; Lindholm J
    Am J Med; 1985 Sep; 79(3):385-8. PubMed ID: 4036988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Acromegaly-gigantism. Clinical and biological study].
    Somma M; Lanthier A
    Neurochirurgie; 1973 May; 19(2):Suppl 2:57-73. PubMed ID: 4752175
    [No Abstract]   [Full Text] [Related]  

  • 25. Changes of carbohydrate tolerance in acromegaly with progress of the disease and in response to treatment.
    Sönksen PH; Greenwood FC; Ellis JP; Lowy C; Rutherford A; Nabarro JD
    J Clin Endocrinol Metab; 1967 Oct; 27(10):1418-30. PubMed ID: 6057823
    [No Abstract]   [Full Text] [Related]  

  • 26. [58-Year Old Woman with Rare Manifestation of Diabetes Mellitus].
    Fröhlich G; Göbel R
    Dtsch Med Wochenschr; 2018 Apr; 143(7):509-510. PubMed ID: 29614543
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of somatostatin in patients with acromegaly: suppression of growth hormone, prolactin, insulin and glucose levels.
    Yen SS; Siler TM; DeVane GW
    N Engl J Med; 1974 Apr; 290(17):935-8. PubMed ID: 4593614
    [No Abstract]   [Full Text] [Related]  

  • 28. Growth hormone and diabetes in man. Old concepts--new implications.
    Luft R; Guillemin R
    Diabetes; 1974 Sep; 23(9):783-7. PubMed ID: 4606596
    [No Abstract]   [Full Text] [Related]  

  • 29. Glucose tolerance in acromegaly: a study of insulin secretion.
    Serrano-Rios M; Rodriguez Miñón JL; Ramos F; Vivanco F
    Isr J Med Sci; 1972 Jun; 8(6):876-7. PubMed ID: 5051828
    [No Abstract]   [Full Text] [Related]  

  • 30. [Therapy of acromegaly using bromocriptine].
    Köbberling J; Schwinn G; Dirks H
    Dtsch Med Wochenschr; 1975 Jul; 100(29):1540-2. PubMed ID: 1149634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chlorpromazine treatment and growth hormone secretory responses in acromegaly.
    Dimond RC; Bramer SR; Atkinson RL; Howard WJ; Earll JM
    J Clin Endocrinol Metab; 1973 Jun; 36(6):1189-95. PubMed ID: 4706207
    [No Abstract]   [Full Text] [Related]  

  • 32. Low serum IGF-I/GH ratio is associated with abnormal glucose tolerance in acromegaly.
    Fukuoka H; Takahashi Y; Iida K; Kudo T; Nishizawa H; Imanaka M; Takeno R; Iguchi G; Takahashi K; Okimura Y; Kaji H; Chihara K
    Horm Res; 2008; 69(3):165-71. PubMed ID: 18219220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The clinical metaboli developmental stages of diabetes mellitus in acromegaly].
    Ioanitziu D; Dragomirescu M; Mitrache L; Hann K
    Z Gesamte Inn Med; 1968 Aug; 23(16):Suppl:241-3. PubMed ID: 5727621
    [No Abstract]   [Full Text] [Related]  

  • 34. Growth hormone and glucose interrelationships in diabetes: studies with insulin infusion during continuous blood glucose analysis.
    Fatourechi V; Molnar GD; Service FJ; Ackerman E; Rosevear JW; Moxness KE; Taylor WF
    J Clin Endocrinol Metab; 1969 Mar; 29(3):319-27. PubMed ID: 5773066
    [No Abstract]   [Full Text] [Related]  

  • 35. Hormonal and metabolic studies of the action of fenfluramine in normal man, obesity, acromegaly and diabetes mellitus.
    Sulaiman WR; Johnson RH; Rennie MJ
    Postgrad Med J; 1975; 51 Suppl 1():125-31. PubMed ID: 1219669
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment with bromocriptine of acromegaly associated with diabetes; with special reference to ability of the drug to improve glucose metabolism disorder].
    Nonaka K; Shimizu T; Miyake S; Watanabe F; Kawano N
    Horumon To Rinsho; 1977 Dec; 25(12):1328-9. PubMed ID: 598036
    [No Abstract]   [Full Text] [Related]  

  • 37. Biochemical evaluation of patients with active acromegaly and type 2 diabetes mellitus: efficacy and safety of the galanin test.
    Mazziotti G; Bonadonna S; Doga M; Patelli I; Gazzaruso C; Solerte SB; De Menis E; Giustina A
    Neuroendocrinology; 2008; 88(4):299-304. PubMed ID: 18617732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Secretin and insulin release in acromegaly.
    Chisholm DJ; Lazarus L; Young JD
    J Clin Endocrinol Metab; 1972 Jul; 35(1):108-12. PubMed ID: 5032508
    [No Abstract]   [Full Text] [Related]  

  • 39. Plasma growth-hormone response to glucocorticoids in diabetics.
    Meek JC; Reitz RP; Bolinger RE
    Proc Soc Exp Biol Med; 1970 Oct; 135(1):123-6. PubMed ID: 5475608
    [No Abstract]   [Full Text] [Related]  

  • 40. Optic atrophy, diabetes mellitus, hypothlamic dysfunction and a small sella turcica.
    Hyams SW; Adar H; Friedman E
    J Pediatr Ophthalmol; 1977; 14(2):106-8. PubMed ID: 874711
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.